Navigation Links
Researchers Discover Breakthrough in Major Third World Scourge

Researchers at the Uniformed Services University of the Health Sciences (USU), The New Jersey Medical School (NJMS), and the U.S. Department of Agriculture// (USDA) have discovered a mechanism that provides natural protection against intestinal roundworm infections, which affect more than 1.4 billion people throughout the world, and which may lead to more effective therapies against nematode parasites.

The breakthrough research in host protection against nematode parasites was published in the August 2006 issue of the prestigious journal, Nature Medicine. The National Institutes of Health funded research was conducted at USU and NJMS by Robert M. Anthony, while a Ph.D. graduate student in USU's Molecular and Cell Biology (MCB) program, under the supervision of the principal investigator, Dr. William Gause. Dr. Joseph Urban, USDA, also collaborated on this project.

Until now, scientists have been unable to determine how the immune system mounts an effective response against tissue dwelling helminthic parasites. The findings of Drs. Anthony, Gause, and co-workers suggest a new model of resistance, involving macrophages. Macrophages have previously been associated primarily with protection against microbes, including bacteria and viruses. The studies reported in Nature Medicine indicate that during helminth infection, macrophages differentiate along an alternative activation pathway that mediates clearance of these relatively large, multicellular parasites.

Dr. Gause, formerly professor and vice chair of the Department of Microbiology and Immunology at USU, is currently university professor and senior associate dean for research at the University of Medicine and Dentistry of New Jersey-NJMS. Dr. Anthony, whose doctoral dissertation is based on this work, is now a postdoctoral fellow at Rockefeller University. Dr. Gause said that this research shows us that macrophages mediate clearance of these parasites and this insight may lead to m ore effective treatments of this important group of pathogens.


Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology: